|
1
|
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.
|
Cell
|
2013
|
6.47
|
|
2
|
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
|
J Virol
|
2006
|
5.41
|
|
3
|
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.
|
J Virol
|
2006
|
4.27
|
|
4
|
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
|
PLoS Pathog
|
2013
|
4.05
|
|
5
|
Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
|
J Virol
|
2004
|
3.17
|
|
6
|
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
|
J Virol
|
2003
|
2.78
|
|
7
|
Experimental approaches to the study of HIV-1 latency.
|
Nat Rev Microbiol
|
2007
|
2.71
|
|
8
|
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
|
J Virol
|
2005
|
2.55
|
|
9
|
Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.
|
J Virol
|
2011
|
2.18
|
|
10
|
Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough.
|
Cell Host Microbe
|
2008
|
2.08
|
|
11
|
Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.
|
PLoS Pathog
|
2013
|
2.02
|
|
12
|
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.
|
J Infect Dis
|
2009
|
1.93
|
|
13
|
Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.
|
J Virol
|
2009
|
1.89
|
|
14
|
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.
|
J Biol Chem
|
2008
|
1.83
|
|
15
|
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
|
PLoS Pathog
|
2007
|
1.81
|
|
16
|
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
|
J Clin Invest
|
2015
|
1.76
|
|
17
|
Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.
|
J Virol
|
2007
|
1.47
|
|
18
|
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.
|
Clin Infect Dis
|
2013
|
1.46
|
|
19
|
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
|
J Infect Dis
|
2010
|
1.45
|
|
20
|
Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model.
|
J Virol
|
2011
|
1.34
|
|
21
|
HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.
|
J Infect Dis
|
2012
|
1.29
|
|
22
|
Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.
|
J Virol
|
2011
|
0.88
|
|
23
|
Recent developments in the effort to cure HIV infection: going beyond N = 1.
|
J Clin Invest
|
2016
|
0.85
|
|
24
|
Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
|
AIDS
|
2010
|
0.85
|
|
25
|
Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173.
|
Antivir Ther
|
2013
|
0.83
|
|
26
|
An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.
|
J Infect Dis
|
2002
|
0.81
|
|
27
|
The Effect of early treatment on the latent reservoir of HIV-1.
|
J Infect Dis
|
2005
|
0.76
|